Free Trial

Allarity Therapeutics Q1 2024 Earnings Report

Allarity Therapeutics logo
$1.02 -0.04 (-3.77%)
As of 04:00 PM Eastern

Allarity Therapeutics EPS Results

Actual EPS
-$664.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Allarity Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Allarity Therapeutics Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Allarity Therapeutics Earnings Headlines

$24 trillion tech spotted at Mar-a-Lago?
President Trump’s Secret Service was recently spotted using an odd new technology at his home in Mar-a-Lago…
Allarity reports progress in Phase 2 stenoparib trial
See More Allarity Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Allarity Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Allarity Therapeutics and other key companies, straight to your email.

About Allarity Therapeutics

Allarity Therapeutics (NASDAQ:ALLR), a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA (ixabepilone), a selective microtubule inhibitor in phase 2 for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. Allarity Therapeutics, Inc. has a collaboration with Detsamma Investments Pty. Ltd. to develop Deflexifol for the treatment of solid tumors. The company was incorporated in 2004 and is headquartered in Boston, Massachusetts.

View Allarity Therapeutics Profile

More Earnings Resources from MarketBeat